A NEW drug to help combat multiple sclerosis was launched in Britain today. Interferon beta-1a is the latest in a new generation of treatments for patients who suffer chronic relapses of MS. However, like drugs of this type it is expensive - about #9500 a year per patient. MS experts today said they feared many of the 8 to10,000 patients who could benefit from the drug will be denied it because of the cost.